5th Gene Therapy Immunogenicity Summit 2024

Kongressthemen
The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies progressing through the pipeline, we need to seek solutions to this critical bottleneck 'here and now'.

Wissenschaftliche Fach-Gesellschaft
Evvnt Promotion / evvnt

Anmerkungen
URL:
Brochure: https://go.evvnt.com/2453359-0?pid=4832

Speakers: Alison Johnson | Principal Scientist | Boehringer Ingelheim, Bala Medicherla | Head, Bioanalytics | Astellas Gene Therapies, and more

https://go.evvnt.com/2453359-2?pid=4832